Boston Beer Company, Inc. (The)

As of September 30, 2026, Boston Beer Company, Inc. (The) carries a market capitalization of 1.67B, placing it among publicly traded companies globally. Its enterprise value stands at 1.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Boston Beer Company, Inc. (The)'s next confirmed earnings release is scheduled for March 2, 2027.

As of September 30, 2026, Boston Beer Company, Inc. (The) has 10.15M shares outstanding.

These figures are as of September 30, 2026. The price-to-sales ratio is 0.90, and the price-to-book ratio stands at 2.26.

These figures are as of September 30, 2026. The EV/Sales ratio of 0.73 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.39B versus a market cap of 1.67B, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2026, Boston Beer Company, Inc. (The) maintains a current ratio of 1.13, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended September 30, 2026, Boston Beer Company, Inc. (The) posted a negative return on equity (ROE) of -8.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.88, reflecting losses generated across the asset base. The company generates approximately 697,387.79 in revenue per employee across its workforce of 2,736.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.72 indicates how many times Boston Beer Company, Inc. (The) sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2026, Boston Beer Company, Inc. (The) recorded an income tax benefit of -15.23M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -88.29M and -73.06M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 27, 2026, Boston Beer Company, Inc. (The)'s stock has declined approximately 11.96% over the past 52 weeks. The 50-day moving average sits at 176.26, while the 200-day moving average is 199.20.

Over the twelve months ended September 30, 2026, Boston Beer Company, Inc. (The) generated 1.91B in revenue and converted that into -73.06M in net income, yielding earnings per share of -7.01. EBITDA reached -10.18M, while operating income came in at 101.78M.

As of September 30, 2026, Boston Beer Company, Inc. (The) holds 308.07M in cash and equivalents against 29.54M in total debt, resulting in a net debt position of -308.07M. Total book value stands at 735.73M, with working capital of 59.58M providing operational flexibility.

Boston Beer Company, Inc. (The) produced 234.14M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -49.08M in capital expenditures, free cash flow totaled 185.06M - equivalent to 17.75 per share.

Over the twelve months ended September 30, 2026, Boston Beer Company, Inc. (The) posted a gross margin of 49.11, reflecting its pricing power and cost economics. The operating margin of 5.33 and net profit margin of -3.83 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 10.82, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.66, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Boston Beer Company, Inc. (The) shareholders.

As of September 30, 2026, Boston Beer Company, Inc. (The) has an Altman Z-Score of 4.09, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.